...Programmed cell death 1 ligand 1 STING (TMEM173) - Transmembrane protein 173 Stephen Hansen, Associate Editor F-star Biotechnology Ltd. Spring...

...Protein engineering The idea behind Denali’s TV platform originated from an antibody-engineering technology developed at F-star Biotechnology Ltd....

...The company expects to produce a GMP compliant compound in 3Q20. F-star’s bispecific checkpoint inhibitor F-star Biotechnology Ltd....
...glutamic acid-rich protein ( P. falciparum GARP) SARS-CoV-2 S - SARS-CoV-2 spike protein BioCentury Staff FS118 Molecular Partners AG F-star Biotechnology Ltd. Programmed...

...of hires Tuesday, including Mihriban Tuna as CSO. She was SVP of drug discovery at F-star Biotechnology Ltd....

...down as CEO of Vaccibody A/S in September; John Haurum, who served as CEO of F-star Biotechnology Ltd....

...and chief commercial officer from SVP, head of North American commercial operations. Bispecific antibody company F-star Biotechnology...
...Diagnostics and is president of American Association for Clinical Chemistry. Jonathan Block, Associate Editor Arbutus Biopharma Arbutus Biopharma Corp. F-star Biotechnology F-star Biotechnology Ltd. Maze...

...company. SVP of Research Daniel Steiner will lead Molecular Partners’ research team. Bispecific antibody company F-star Biotechnology Ltd....
...Ltd. (Beersheba, Israel), both of which he co-founded. BioCentury Staff Agios Pharmaceuticals Inc. Biophytis S.A. Celsius Therapeutics eGenesis Inc. EyePoint Pharmaceuticals Inc. F-star Biotechnology Ltd. Medicure...

...efficacy. Other companies presenting dual checkpoint bispecifics at ASCO include MacroGenics Inc., Alligator Biosciences AB, F-Star Biotechnology Ltd....
...Shanghai, China Chinese PLA General Hospital, Beijing, China Eli Lilly and Co. (NYSE:LLY), Indianapolis, Ind. F-star Biotechnology Ltd....
...Hematology Amgen Inc. Baylor College of Medicine Bellicum Pharmaceuticals Inc. CARsgen Therapeutics Co. Ltd. Chinese PLA General Hospital Eli Lilly and Co. F-star Biotechnology Ltd. Huazhong...

...F-star to keep lead bispecific in new deal with Merck KGaA F-star Biotechnology Ltd. (Cambridge, U.K.) reconfigured its...
...PDUFA date is Nov. 9. Elizabeth S. Eaton, Staff Writer FS118 Humira, adalimumab (D2E7) Tlando, testosterone undecanoate (LPCN 1021) AbbVie Inc. F-star Biotechnology Ltd. Ipsen...

...and chief development officer at argenx S.E. (Euronext:ARGX; NASDAQ:ARGX). John Haurum, most recently CEO of F-star Biotechnology Ltd....